Viridian Therapeutics Inc (NASDAQ:VRDN)

Delayed Data
As of Aug 05
 +0.06 / +0.44%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Viridian Therapeutics Inc have a median target of 32.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +134.26% increase from the last price of 13.66.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Viridian Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.45%
Growthannually 43.20%


Growthquarterly 25.15%
Growthannually -70.49%
Key to the earnings and sales forecast charts.